Clinical Conductor CTMS and OpenClinica will deliver a seamless EDC-CTMS integration under a new strategic partnership.
Clinical Conductor CTMS, a clinical trial management system provided by Bio-Optronics, and OpenClinica, an open source EDC software platform, will deliver a seamless EDC-CTMS integration under a new strategic partnership.
Beginning immediately, Clinical Conductor CTMS will begin offering the OpenClinica Enterprise Edition EDC as part of its product offerings for clinical research management. This integrated solution offers a seamless trial and data management experience. The integrated systems exchange critical information pertaining to patient details, study protocols, CRFs, and more.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Merck Launches Phase III Trials of Once-Monthly Oral HIV PrEP Candidate MK-8527
July 14th 2025In the new EXPrESSIVE clinical trial program, Merck will evaluate MK-8527, a once-monthly, oral PrEP therapy, in populations at high risk of HIV-1 infection, including adolescent girls and women in sub-Saharan Africa.
Baxdrostat Shows Significant Blood Pressure Reduction in Phase III BaxHTN Trial
July 14th 2025In the BaxHTN Phase III study, AstraZeneca’s baxdrostat demonstrated statistically significant and clinically meaningful reductions in systolic blood pressure in patients with uncontrolled or treatment-resistant hypertension.